Vitaspring Biomedical Co. Ltd.
VSBC· OTC
VSBCVitaspring Biomedical Co. Ltd.
Filed Jun 8, 2026 · 10-K · 493 days after period end · 0001640334-26-001019
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | — | — |
| Net Income | -$143.14K | -$225.40K | -$4.16M | $17.27K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vitaspring Biomedical Co. Ltd. · CIK 1697884 · Engraved from SEC EDGAR
ended Jan 31, 2025 · filed Jun 8, 2026 · 493 d after period end
